BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gatla HR, Muniraj N, Thevkar P, Yavvari S, Sukhavasi S, Makena MR. Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases. Int J Mol Sci 2019;20:E1110. [PMID: 30841513 DOI: 10.3390/ijms20051110] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Yang F, Hu T, Liu J, Yu X, Ma L. Histone deacetylases (HDACs) as the promising immunotherapeutic targets for hematologic cancer treatment. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114920] [Reference Citation Analysis]
2 Truong N, Goodis CC, Cottingham AL, Shaw JR, Fletcher S, Pearson RM. Modified Suberoylanilide Hydroxamic Acid Reduced Drug-Associated Immune Cell Death and Organ Damage under Lipopolysaccharide Inflammatory Challenge. ACS Pharmacol Transl Sci . [DOI: 10.1021/acsptsci.2c00119] [Reference Citation Analysis]
3 Brindisi M, Barone S, Rossi A, Cassese E, Del Gaudio N, Feliz Morel ÁJ, Filocamo G, Alberico A, De Fino I, Gugliandolo D, Babaei M, Bove G, Croce M, Montesano C, Altucci L, Bragonzi A, Summa V. Efficacy of selective histone deacetylase 6 inhibition in mouse models of Pseudomonas aeruginosa infection: A new glimpse for reducing inflammation and infection in cystic fibrosis. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.175349] [Reference Citation Analysis]
4 Harrison C, Heidel FH, Vannucchi AM, Kiladjian J, Hayat A, Passamonti F, Conneally E, Kindler T, Martino B, Lipka DB, Stefanelli T, Roussou P, Germano D, Ewan J, Ribrag V. A Phase Ib Dose-finding Study of Panobinostat and Ruxolitinib in Myelofibrosis. HemaSphere 2022;6:e757. [DOI: 10.1097/hs9.0000000000000757] [Reference Citation Analysis]
5 Janbazacyabar H, van Bergenhenegouwen J, Varasteh S, Garssen J, Folkerts G, Braber S. Repeated exposure of bronchial epithelial cells to particular matter increases allergen-induced cytokine release and permeability. Cytokine 2022;154:155878. [DOI: 10.1016/j.cyto.2022.155878] [Reference Citation Analysis]
6 Snaider S, Zheng Y, Hearing P. Rb-E2F-HDAC Repressor Complexes Control Interferon-Induced Repression of Adenovirus To Promote Persistent Infection. J Virol 2022;:e0044222. [PMID: 35546119 DOI: 10.1128/jvi.00442-22] [Reference Citation Analysis]
7 Renzini A, D’onghia M, Coletti D, Moresi V. Histone Deacetylases as Modulators of the Crosstalk Between Skeletal Muscle and Other Organs. Front Physiol 2022;13:706003. [DOI: 10.3389/fphys.2022.706003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Barone S, Cassese E, Alfano AI, Brindisi M, Summa V. Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology. J Med Chem 2022. [PMID: 35148101 DOI: 10.1021/acs.jmedchem.1c02067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
9 Shanmugam G, Rakshit S, Sarkar K. HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases. Transl Oncol 2021;16:101312. [PMID: 34922087 DOI: 10.1016/j.tranon.2021.101312] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
10 Mao C, Ding Y, Xu N. A Double-Edged Sword Role of Cytokines in Prostate Cancer Immunotherapy. Front Oncol 2021;11:688489. [PMID: 34868907 DOI: 10.3389/fonc.2021.688489] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
11 Karoor V, Strassheim D, Sullivan T, Verin A, Umapathy NS, Dempsey EC, Frank DN, Stenmark KR, Gerasimovskaya E. The Short-Chain Fatty Acid Butyrate Attenuates Pulmonary Vascular Remodeling and Inflammation in Hypoxia-Induced Pulmonary Hypertension. Int J Mol Sci 2021;22:9916. [PMID: 34576081 DOI: 10.3390/ijms22189916] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
12 Dai Y, Wei T, Shen Z, Bei Y, Lin H, Dai H. Classical HDACs in the regulation of neuroinflammation. Neurochem Int 2021;150:105182. [PMID: 34509559 DOI: 10.1016/j.neuint.2021.105182] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
13 Bieszczad B, Garbicz D, Świtalska M, Dudek MK, Warszycki D, Wietrzyk J, Grzesiuk E, Mieczkowski A. Improved HDAC Inhibition, Stronger Cytotoxic Effect and Higher Selectivity against Leukemias and Lymphomas of Novel, Tricyclic Vorinostat Analogues. Pharmaceuticals (Basel) 2021;14:851. [PMID: 34577551 DOI: 10.3390/ph14090851] [Reference Citation Analysis]
14 Shokoohian B, Negahdari B, Aboulkheyr Es H, Abedi-Valugerdi M, Baghaei K, Agarwal T, Maiti TK, Hassan M, Najimi M, Vosough M. Advanced therapeutic modalities in hepatocellular carcinoma: Novel insights. J Cell Mol Med 2021;25:8602-14. [PMID: 34423899 DOI: 10.1111/jcmm.16875] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
15 Ekronarongchai S, Palaga T, Saonanon P, Pruksakorn V, Hirankarn N, van Hagen PM, Dik WA, Virakul S. Histone Deacetylase 4 Controls Extracellular Matrix Production in Orbital Fibroblasts from Graves' Ophthalmopathy Patients. Thyroid 2021. [PMID: 34235979 DOI: 10.1089/thy.2020.0948] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Al-Saleem J, Granet R, Ramakrishnan S, Ciancetta NA, Saveson C, Gessner C, Zhou Q. Knowledge Graph-Based Approaches to Drug Repurposing for COVID-19. J Chem Inf Model 2021;61:4058-67. [PMID: 34297570 DOI: 10.1021/acs.jcim.1c00642] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
17 Mitini-Nkhoma SC, Chimbayo ET, Mzinza DT, Mhango DV, Chirambo AP, Mandalasi C, Lakudzala AE, Tembo DL, Jambo KC, Mwandumba HC. Something Old, Something New: Ion Channel Blockers as Potential Anti-Tuberculosis Agents. Front Immunol 2021;12:665785. [PMID: 34248944 DOI: 10.3389/fimmu.2021.665785] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
18 Hu C, Peng K, Wu Q, Wang Y, Fan X, Zhang DM, Passerini AG, Sun C. HDAC1 and 2 regulate endothelial VCAM-1 expression and atherogenesis by suppressing methylation of the GATA6 promoter. Theranostics 2021;11:5605-19. [PMID: 33859766 DOI: 10.7150/thno.55878] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
19 Ullmann T, Luckhardt S, Wolf M, Parnham MJ, Resch E. High-Throughput Screening for CEBPD-Modulating Compounds in THP-1-Derived Reporter Macrophages Identifies Anti-Inflammatory HDAC and BET Inhibitors. Int J Mol Sci 2021;22:3022. [PMID: 33809617 DOI: 10.3390/ijms22063022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
20 Makena MR, Ko M, Dang DK, Rao R. Epigenetic Modulation of SPCA2 Reverses Epithelial to Mesenchymal Transition in Breast Cancer Cells. Cancers (Basel) 2021;13:E259. [PMID: 33445642 DOI: 10.3390/cancers13020259] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Ganesan A. The clinical landscape of HDAC inhibitors. Medical Epigenetics 2021. [DOI: 10.1016/b978-0-12-823928-5.00036-0] [Reference Citation Analysis]
22 Kyrke-Smith M, Logan B, Abraham WC, Williams JM. Bilateral histone deacetylase 1 and 2 activity and enrichment at unique genes following induction of long-term potentiation in vivo. Hippocampus 2021;31:389-407. [PMID: 33378103 DOI: 10.1002/hipo.23297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Maharaj K, Powers JJ, Mediavilla-Varela M, Achille A, Gamal W, Quayle S, Jones SS, Sahakian E, Pinilla-Ibarz J. HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model. Front Immunol 2020;11:590072. [PMID: 33329575 DOI: 10.3389/fimmu.2020.590072] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
24 Naeimi Kararoudi M, Tullius BP, Chakravarti N, Pomeroy EJ, Moriarity BS, Beland K, Colamartino ABL, Haddad E, Chu Y, Cairo MS, Lee DA. Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activity. Semin Hematol 2020;57:201-12. [PMID: 33256913 DOI: 10.1053/j.seminhematol.2020.11.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
25 Jiang Y, Xu Z, Ma N, Yin L, Hao C, Li J. Effects of signaling pathway inhibitors on hematopoietic stem cells. Mol Med Rep 2021;23:9. [PMID: 33179097 DOI: 10.3892/mmr.2020.11647] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
26 Makena MR, Ko M, Dang DK, Rao R. Epigenetic Modulation of SPCA2 Reverses Epithelial to Mesenchymal Transition in Breast Cancer Cells.. [DOI: 10.1101/2020.11.12.379685] [Reference Citation Analysis]
27 Chen X, He Y, Fu W, Sahebkar A, Tan Y, Xu S, Li H. Histone Deacetylases (HDACs) and Atherosclerosis: A Mechanistic and Pharmacological Review. Front Cell Dev Biol. 2020;8:581015. [PMID: 33282862 DOI: 10.3389/fcell.2020.581015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
28 Makena MR, Nguyen TH, Koneru B, Hindle A, Chen WH, Verlekar DU, Kang MH, Reynolds CP. Vorinostat and fenretinide synergize in preclinical models of T-cell lymphoid malignancies. Anticancer Drugs 2021;32:34-43. [PMID: 33079733 DOI: 10.1097/CAD.0000000000001008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
29 He F, Ran Y, Li X, Wang D, Zhang Q, Lv J, Yu C, Qu Y, Zhang X, Xu A, Wei C, Chou CJ, Wu J. Design, synthesis and biological evaluation of dual-function inhibitors targeting NMDAR and HDAC for Alzheimer’s disease. Bioorganic Chemistry 2020;103:104109. [DOI: 10.1016/j.bioorg.2020.104109] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
30 Sevastre-Berghian AC, Ielciu I, Mitre AO, Filip GA, Oniga I, Vlase L, Benedec D, Gheldiu AM, Toma VA, Mihart B, Mihuţ A, Bâldea I, Olteanu D, Chis IC, Clichici SV, Hanganu D. Targeting Oxidative Stress Reduction and Inhibition of HDAC1, MECP2, and NF-kB Pathways in Rats With Experimentally Induced Hyperglycemia by Administration of Thymus marshallianus Willd. Extracts. Front Pharmacol 2020;11:581470. [PMID: 33071792 DOI: 10.3389/fphar.2020.581470] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
31 Beacon TH, Su RC, Lakowski TM, Delcuve GP, Davie JR. SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics. IUBMB Life 2020;72:2331-54. [PMID: 32936531 DOI: 10.1002/iub.2379] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
32 Báez-Magaña M, Alva-Murillo N, Medina-Estrada I, Arceo-Martínez MT, López-Meza JE, Ochoa-Zarzosa A. Plant Defensin γ-Thionin Induces MAPKs and Activates Histone Deacetylases in Bovine Mammary Epithelial Cells Infected With Staphylococcus aureus. Front Vet Sci 2020;7:390. [PMID: 32793642 DOI: 10.3389/fvets.2020.00390] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Zhang Y, Li M, Wang Y, Liu X, Zhou L, Zhang C, Shao L. Histone deacetylase inhibition by MS-275 potentiates glucose-stimulated insulin secretion without affecting glucose oxidation. Life Sci 2020;257:118073. [PMID: 32663574 DOI: 10.1016/j.lfs.2020.118073] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
34 Liu H, Byrne M, Perlmutter P, Walker A, Sama GR, Subbiah J, Ozcelik B, Widdop RE, Gaspari TA, Byron K, Chen YC, Kaye DM, Dear AE. A Novel Epigenetic Drug-Eluting Balloon Angioplasty Device: Evaluation in a Large Animal Model of Neointimal Hyperplasia. Cardiovasc Drugs Ther 2019;33:687-92. [PMID: 31885055 DOI: 10.1007/s10557-019-06921-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Jannat Ali Pour N, Meshkani R, Toolabi K, Mohassel Azadi S, Zand S, Emamgholipour S. Adipose tissue mRNA expression of HDAC1, HDAC3 and HDAC9 in obese women in relation to obesity indices and insulin resistance. Mol Biol Rep 2020;47:3459-68. [PMID: 32277440 DOI: 10.1007/s11033-020-05431-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
36 Lobo J, Jerónimo C, Henrique R. Targeting the Immune system and Epigenetic Landscape of Urological Tumors. Int J Mol Sci 2020;21:E829. [PMID: 32012885 DOI: 10.3390/ijms21030829] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
37 Ganesan A. HDAC inhibitors in cancer therapy. Histone Modifications in Therapy 2020. [DOI: 10.1016/b978-0-12-816422-8.00002-7] [Reference Citation Analysis]
38 Chaix R, Fagny M, Cosin-Tomás M, Alvarez-López M, Lemee L, Regnault B, Davidson RJ, Lutz A, Kaliman P. Differential DNA methylation in experienced meditators after an intensive day of mindfulness-based practice: Implications for immune-related pathways. Brain Behav Immun 2020;84:36-44. [PMID: 31733290 DOI: 10.1016/j.bbi.2019.11.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
39 Makena MR, Rao R. Subtype specific targeting of calcium signaling in breast cancer. Cell Calcium 2020;85:102109. [PMID: 31783287 DOI: 10.1016/j.ceca.2019.102109] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
40 Kim M, Kwon Y, Jung HS, Kim Y, Jeoung D. FcεRI-HDAC3-MCP1 Signaling Axis Promotes Passive Anaphylaxis Mediated by Cellular Interactions. Int J Mol Sci 2019;20:E4964. [PMID: 31597362 DOI: 10.3390/ijms20194964] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
41 Ram Makena M, Gatla H, Verlekar D, Sukhavasi S, K Pandey M, C Pramanik K. Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance. Int J Mol Sci 2019;20:E4242. [PMID: 31480221 DOI: 10.3390/ijms20174242] [Cited by in Crossref: 69] [Cited by in F6Publishing: 73] [Article Influence: 23.0] [Reference Citation Analysis]